Explore Acoustic Cell Handling in Your Process
Modular Type Package (MTP) offer
Aenitis offers Modular Type Package (MTP) business solutions to enable the seamless integration of acoustic cell handling steps into your existing bioprocess workflows.
This approach allows our technology to be embedded at any stage; sorting, washing, isolation, or concentration; providing flexible, scalable, and GMP-ready solutions tailored to your process.
Collaboration models include:
- Co-development from proof-of-concept to GMP manufacturing
- Custom consumable production for existing platforms
- Licensing of our acoustic technology
- Rapid user training (approximately 30 minutes for full autonomy)
- Designed collaboratively with research laboratories for intuitive usability
Modular Production and Scalability
Aenitis is developing a flexible and modular manufacturing approach based on a modular factory capabilities allowing rapid design and manufacturing of single-use custom consumables in compliance with GMP standards and adapted to CGT volumes needs:
- Prototype in as little as 1 month
- Serial production within 4 months, plus regulatory validation (biocompatibility, cytotoxicity, etc.)
- Demonstrated scalability from custom designs to mass-produced plastic injection components
- Scaling to more conventional full plastic injection production should require 12–18 months, including mould development and regulatory qualification if need (GMP compliance)
- Production leverages 3D printing for plastic parts, automation for assembly and testing, and sheet metal fabrication for metallic components
This approach enables faster, cost-effective production of tailored consumables, a key advantage for advanced therapies where traditional injection molding is too slow or inflexible.
Key Differentiators
- Scientifically and technically validated solution
- Scalable to industrial production levels
- Flexible, modular manufacturing approach
- Rapid customization capabilities
Ready to try?
Please fill this form and we will get back to you as soon as possible
Aenitis development pipeline
Versatile devices for lab purpose. Increase recovery yield. Less cells damaged – MitisTM
New production facility for disposables in Modular Plant
Platelets isolation from PRP: No platelet activation
Project on standby due to change in MDR in EU and lack of notified body + Mature Market warnings
Rare and complex cell sorting « acoustic beads »
Induce low density on targeted cells in flow: Isolation of TL with mAB anti-CD3 from PBMC as a 1st demo. Alternative to magnetic beads
Demo on PBMC expected by Sept. 2025
Gentle Cell concentration
MSC post Bioreactor / Expansion: Increase recovery yield. Less cells damaged
In discussion for moving forward with a new bioreactor type
WBC pre transfection or post expansion: In flow system pre electroporation or sonoporation
Work in progress with Inserm and in parallel with potential industrial partner (confidential)
iPSC post bioreactor / expansion: Increase recovery yield. Less loss. No unexpected activation.
Tests on different type of iPSC to be proceeded by Oct. 2025
Transduction boost
Increase of membrane-vector fusion: Increase transduction yield
Word on reproducibility. 20% to 50% boost.
IPSC washing
In flow washing in perfusion: Increase recovery yield. No cell unexpected activation or loss.
Project linked to an industrial therapeutic cell production plant. Next step will be on a selected iPSC.